A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung Cancer

NCT05186506 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

152

Enrollment

OTHER

Sponsor class

Conditions

ALK Fusion Protein Expression
Adjuvant Therapy
Non-Small Cell Lung Cancer

Interventions

DRUG: Ensatinib
DRUG: chemotherapy

Sponsor

Sichuan University

Collaborators

[object Object]